Table 2.
Risk factors associated with candida infection, results of univariate analysis and multivariate analysis
Risk factors | Patient | Cohort | P | |||
---|---|---|---|---|---|---|
N | % | N | % | |||
Antibiotic therapy | 61 | 96,8 | 60 | 95,2 | 0,64 | |
Antacid therapy | 56 | 88,9 | 60 | 95,2 | 0,18 | |
UC | 54 | 85,7 | 56 | 88,9 | 0,5 | |
TPN | 48 | 76,2 | 45 | 71,4 | 0,54 | |
Chronic disease | 46 | 73 | 42 | 66,7 | 0,43 | |
CVC | 44 | 69,8 | 33 | 52,4 | 0,04* | |
MR | 35 | 55,6 | 26 | 41,3 | 0,1 | |
Hyperglycemia | 12 | 19 | 1 | 1,6 | 0,001* | |
Co- infections | 45 | 71,4 | 21 | 33,3 | 0* | |
Risk factors | OR | 95 CI | P | |||
Hospital day | 1,03 | 1,01-1,05 | 0,007 | |||
Hyperglycemia | 17,93 | 2,03-158,49 | 0,009 | |||
Co- infections | 3,98 | 1,72-9,21 | 0,001 |
CVC: Central venous catheter, UC: Urinary catheter, TPN: total parenteral nutrition
Statistically significant